Zobrazeno 1 - 5
of 5
pro vyhledávání: '"O. L. Fakhrutdinova"'
Autor:
M. Yu. Fedyanin, L. Yu. Vladimirova, V. A. Chubenko, L. A. Zagorskaya, A. V. Belyaeva, O. L. Fakhrutdinova, S. A. Belukhin, A. S. Zhabina, L. V. Khalikova, L. V. Bolotina, R. V. Orlova, F. V. Moiseenko, G. Z. Mukhametshina, A. I. Khasanova, A. V. Belonogov, Kh. S. Musaeva, O. Yu. Novikova, I. Yu. Stradaeva, I. L. Popova, S. P. Erdniev, A. K. Ivanova, A. V. Androsova, P. S. Feoktistova, E. S. Kuzmina, E. V. Karabina, O. V. Nekrasova, O. V. Sekhina, A. A. Mishchenko, L. A. Mukova, B. Kh. Kertiev, G. I. Kosar, S. N. Osodoeva, A. I. Kats, R. R. Malina, M. A. Lyadova, A. A. Tryakin, S. A. Tyulandin
Publikováno v:
Тазовая хирургия и онкология, Vol 11, Iss 3-4, Pp 11-17 (2022)
Objective: to compare the efficacy and toxicity of aflibercept and bevacizumab in combination with fOLfIRI in secondline therapy for patients with metastatic colon cancer.Materials and methods. we performed a retrospective analysis of data on patient
Externí odkaz:
https://doaj.org/article/2d03f1018a45430f833cbda769ac5776
Autor:
M. Yu. Fedyanin, L. Yu. Vladimirova, V. A. Chubenko, L. A. Zagorskaya, A. V. Belyaeva, L. V. Bolotina, F. V. Moiseenko, O. L. Fakhrutdinova, S. A. Belukhin, A. S. Zhabina, L. V. Khalikova, V. M. Moiseenko, А. А. Meshcheryakov, E. V. Artamonova, I. A. Pokataev, A. I. Khasanova, A. V. Belonogov, Kh. S. Musaeva, O. Yu. Novikova, I. Yu. Stradaeva, I. L. Popova, G. Z. Mukhametshina, R. V. Orlova, S. P. Erdniev, A. K. Ivanova, A. V. Androsova, P. S. Feoktistova, E. S. Kuzmina, E. V. Karabina, O. V. Nekrasova, V. M. Sherstnev, A. A. Mishchenko, L. A. Mukova, B. Kh. Kertiev, G. I. Kosar, S. N. Osodoeva, A. I. Kats, R. R. Malina, A. A. Tryakin, S. A. Tjulandin
Publikováno v:
Тазовая хирургия и онкология, Vol 9, Iss 2, Pp 29-37 (2019)
Objective: to identify factors associated with efficacy of an aflibercept-chemotherapy combination in patients with metastatic colon cancer.Materials and methods. This retrospective multicenter study was conducted in 20 clinics from 15 regions of the
Externí odkaz:
https://doaj.org/article/743bdd161bd0481991ada713bfba7dbc
Publikováno v:
Тазовая хирургия и онкология, Vol 0, Iss 3, Pp 42-45 (2015)
Pathologic nutrients metabolism presents a severe problem in metastatic colorectal cancer patients, especially those with canceromatosis. A hypermetabolism-catabolism syndrome frequently develops in in patients with progressing canceromatosis. This l
Externí odkaz:
https://doaj.org/article/5349b91e400748b78d6c94cded5abd58
Autor:
M. Yu. Fedyanin, L. A. Zagorskaya, O. L. Fakhrutdinova, O. V. Nekrasova, S. A. Belukhin, A. A. Mishchenko, L. Yu. Vladimirova, Alfia Khasanova, B. Kh. Kertiev, Ye. V. Karabina, A. K. Ivanova, A. V. Belyayeva, Viacheslav Chubenko, A. V. Androsova, Alexey Tryakin, P S Feoktistova, Rashida Orlova, Guzel Mukhametshina, S. N. Osodoyeva, R. R. Malina, I. A. Pokatayev, O. Yu. Novikova, L. V. Khalikova, V. M. Sherstnev, A. A. Meshcheryakov, Sanal Erdniev, Elena Artamonova, Kh. S. Musayeva, Irina L. Popova, L. A. Mukova, Larisa Bolotina, F. V. Moiseyenko, A. I. Katz, Ye. S. Kuzmina, G. I. Kosar, I. Yu. Stradayeva, Vladimir Moiseyenko, S. A. Tyulyandin, A S Zhabina, A. Belonogov
Publikováno v:
Malignant tumours. 9:53-63
Purpose. To assess the incidence and severity of adverse events; to explore clinical factors associated with grade 3–4 non-hematologic toxicity; to assess the immediate efficacy and progression-free survival during treatment with the FOLFIRI regime
Publikováno v:
Voprosy onkologii. 57(6)
Tumor cells can acquire the mechanisms of immune response evasion. One of these mechanisms is synthesis and secretion in the microenvironment of immunosuppressive factors able to block immune cells maturation and function. We investigated plasma leve